Stanford Health Care

Research CenterTreats all valves

AI Description

Stanford Health Care provides heart valve evaluation and treatment through its Valvular Heart Disease Clinic, Structural Heart Program, TAVR Program, interventional cardiology, and heart surgery teams. Care includes valve repair or replacement, minimally invasive transcatheter aortic valve replacement (TAVR), transcatheter mitral valve repair, balloon valvuloplasty, and surgery for aortic, mitral, tricuspid, and pulmonary valve disease, with cardiologists, surgeons, heart failure specialists, and imaging specialists involved in planning.

This description was generated by AI based on public sources. Data Sources and Methodology · Report inaccurate information

Location and Contact

300 Pasteur Drive
Stanford, CA 94305

Clinical Trials

Active, not recruiting

CLASP IID/IIF

Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial

Public sites
60
Start date
Nov 30, 2018
Active, not recruiting

SURTAVI

Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).

Public sites
56
Start date
Apr 1, 2012
Active, not recruiting

SUMMIT

Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation

Public sites
71
Start date
Jun 15, 2018
Active, not recruiting

EARLY TAVR

EARLY TAVR: Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis

Public sites
66
Start date
Jul 12, 2017
Recruiting

ENVISION

ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation

Public sites
67
Start date
Mar 15, 2024
Recruiting

CLASP II TR

Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

Public sites
70
Start date
Dec 11, 2019
Recruiting

JOURNEY

J-Valve Transfemoral Pivotal Study

Public sites
31
Start date
Oct 17, 2024
Active, not recruiting

P3

PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis

Public sites
62
Start date
Mar 1, 2016
Recruiting

PROGRESS

PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR

Public sites
57
Start date
Oct 12, 2021
Active, not recruiting

PRIMARY

Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)

Public sites
22
Start date
Feb 21, 2022
Active, not recruiting

PORTICO-IDE

Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial

Public sites
59
Start date
May 1, 2014
Recruiting

RESTORE

REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

Public sites
65
Start date
Feb 6, 2025
Recruiting

TWIST-EFS

TVMR With the INNOVALVE System Trial - Early Feasibility Study

Public sites
19
Start date
Sep 1, 2022
Recruiting

APOLLO

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

Public sites
71
Start date
Oct 23, 2017
Active, not recruiting

ReChord

Randomized Trial of the Neochord DS1000 System Versus Open Surgical Repair

Public sites
12
Start date
Nov 3, 2016
Recruiting

TP-TAVR

Transpacific TAVR Registry

Public sites
2
Start date
Jun 15, 2019

Nearby Centers